[1]
“A CASE OF MONOCLONAL ANTIBODY (RITUXIMAB) INDUCED POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME (PRES) IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS”, RJDNMD, vol. 31, no. 1, pp. 698–704, Apr. 2024, Accessed: May 18, 2024. [Online]. Available: https://jrdiabet.ro/index.php/RJDNMD/article/view/335